300583 赛托生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-3.841-4.6102.4442.4672.177
总资产报酬率 ROA (%)-2.350-2.8331.4631.4071.246
投入资产回报率 ROIC (%)-2.569-3.1311.6621.6511.456

边际利润分析
销售毛利率 (%)12.52819.13322.31220.79222.084
营业利润率 (%)-9.896-10.5152.5583.7524.654
息税前利润/营业总收入 (%)-6.896-7.2647.0906.3276.971
净利润/营业总收入 (%)-10.562-10.4403.7933.2362.976

收益指标分析
经营活动净收益/利润总额(%)62.72953.08166.44493.42494.454
价值变动净收益/利润总额(%)-7.169-12.0196.75416.6897.312
营业外收支净额/利润总额(%)1.4140.66838.783-2.743-3.102

偿债能力分析
流动比率 (X)1.2111.2551.4171.0511.024
速动比率 (X)0.7060.6250.6840.4900.520
资产负债率 (%)37.15337.73036.25640.88641.677
带息债务/全部投入资本 (%)31.88731.75028.15032.58532.046
股东权益/带息债务 (%)210.596209.974245.515204.788209.471
股东权益/负债合计 (%)165.856161.094171.277140.442135.957
利息保障倍数 (X)-2.195-2.1872.4352.3652.837

营运能力分析
应收账款周转天数 (天)78.58687.81965.92053.65244.208
存货周转天数 (天)235.015313.608240.947197.357204.324